Notices for publication in the OJ nº T-104/19 of Tribunal General de la Unión Europea, July 24, 2020

• Resolution Date: July 24, 2020
• Issuing Organization: Tribunal General de la Unión Europea
• Decision Number: T-104/19

Judgment of the General Court of 25 June 2020 - Dermavita v EUIPO - Allergan Holdings France (JUVÉDERM)

(Case T-104/19) ¹

(EU trade mark - Revocation proceedings - EU word mark JUVÉDERM - Genuine use of the mark - Use in connection with the goods in respect of which the mark was registered - Use in the form in which the mark was registered - Use with the proprietor’s consent - Article 51(1)(a) of Regulation (EC) No 207/2009 (now Article 58(1)(a) of Regulation (EU) 2017/1001))

Language of the case: English

Parties

Applicant: Dermavita Co. Ltd (Beirut, Lebanon) (represented by: G. Paricheva, lawyer)

Defendant: European Union Intellectual Property Office (represented by: K. Zajfert, J. Crespo Carrillo, H. O’Neill and V. Ruzek, acting as Agents)

Other party to the proceedings before the Board of Appeal of EUIPO, intervener before the General Court: Allergan Holdings France (Courbevoie, France) (represented by: J. Day, Solicitor, and T. de Haan, lawyer)

Re:

Action brought against the decision of the Fourth Board of Appeal of EUIPO of 19 December 2018 (Case R 2630/2017-4), relating to revocation proceedings between Dermavita and Allergan Holdings France.

Operative part of the judgment

The Court:

...